COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey

CompletedOBSERVATIONAL

Enrollment

179

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

April 8, 2021

Study Completion Date

August 22, 2021

Conditions

SARS-COV2 Infection

Interventions

DIAGNOSTIC_TEST

blood test for SARS-COV2 serology

each person who will accept to participate will have a bood test for a SARS-COV2 serology

Trial Locations (3)

Haltes pour femmes, Paris

LHSS Saint-Michel, Paris

LHSS Ridder-Plaisance, Paris

All Listed Sponsors

collaborator

Samusocial de Paris

UNKNOWN

collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT04470648 - COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey | Biotech Hunter | Biotech Hunter